573. Deputy Colm Burke asked the Minister for Health the reason health technology assessments for medicinal products only consider clinical effectiveness, cost effectiveness and budget impact when assessing a medicines’ value; the reason other elements of the general criteria for assessing a medicine under section 19 of the Health Act 2004 are not considered, including the health needs of the public and the clinical need for the item listed; and if he will make a statement on the matter. [51077/23]

Summary

573. Deputy Colm Burke asked the Minister for Health the reason health technology assessments for medicinal products only consider clinical effectiveness, cost effectiveness and budget impact when assessing a medicines’ value; the reason other elements of the general criteria for assessing a medicine under section 19 of the Health Act 2004 are not considered, including the health needs of the public and the clinical need for the item listed; and if he will make a statement on the matter. [51077/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 21 November 2023

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.